# TIGECYCLINE
> **ANDA204439** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2018-12-21
## Drug
- **FDA Application Number:** ANDA204439
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TIGECYCLINE
- **Generic name:** TIGECYCLINE
- **Active ingredients:** TIGECYCLINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **Manufacturer:** Apotex Corp
- **First approval:** 2018-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204439)
---
*MORVS · CC0 1.0*